United Biotech (P) Limited, India : Pharmaceutical Business

::	Research & Development
::	International Collaboration
::	Business Opportunities
::	Latest Events
::	Divisions At a Glance

:: Press Releases

:: In Licensing

:: Out Licensing

Ondansetron Injection USP 4 mg

Indications :

Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.

Prevention of postoperative nausea and or vomiting. In patients where nausea and/or vomiting must be avoided postoperatively.

Prevention of nausea and vomiting associated with radiotherapy in patients receiving total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen.

Recommended where the incidence of postoperative nausea and/or vomiting is low.

Dosage :

Chemotherapy – induced Nausea & Vomiting

Adults :
IV Dose : 32mg IV or 150 mcg per kg of body weight.

Children : 150 mcg per kg body weight (6 months to 18 years).

For prevention of postoperative nausea and vomiting

Adults :
IV Dose : 4 mg IV over a period of thirty sec. to five min. (Given just before anesthesia).

Children (1 month to 12 years) : 100mcg/kg of weight for children weighing 40 kg or less, or 4 mg for children weighing over 40 kg.

Packing :

10 Packs of 5 ampoules of 4 mg/2 ml

Home

Careers

Site map